Eli Lilly (LLY) Restructuring Costs (2016 - 2025)
Historic Restructuring Costs for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to $84.1 million.
- Eli Lilly's Restructuring Costs fell 7558.07% to $84.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $484.0 million, marking a year-over-year decrease of 4378.63%. This contributed to the annual value of $484.0 million for FY2025, which is 4378.63% down from last year.
- Latest data reveals that Eli Lilly reported Restructuring Costs of $84.1 million as of Q4 2025, which was down 7558.07% from $364.9 million recorded in Q3 2025.
- Over the past 5 years, Eli Lilly's Restructuring Costs peaked at $435.0 million during Q2 2024, and registered a low of $35.0 million during Q1 2025.
- For the 5-year period, Eli Lilly's Restructuring Costs averaged around $179.4 million, with its median value being $104.5 million (2021).
- Its Restructuring Costs has fluctuated over the past 5 years, first soared by 44717.61% in 2021, then tumbled by 7558.07% in 2025.
- Eli Lilly's Restructuring Costs (Quarter) stood at $104.5 million in 2021, then plummeted by 63.54% to $38.1 million in 2022, then soared by 78.48% to $68.0 million in 2023, then surged by 406.47% to $344.4 million in 2024, then plummeted by 75.58% to $84.1 million in 2025.
- Its Restructuring Costs was $84.1 million in Q4 2025, compared to $364.9 million in Q3 2025 and $35.0 million in Q1 2025.